StockData
PROCEPT BioRobotics Corp logo

PROCEPT BioRobotics Corp (PRCT) stock

PRCTNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 4, 2026Score 10/3049% below fair value
$23.78+0.24 (+1.02%)

Close on Nov 17, 2026Market cap $1.36BP/E –Yield –

PROCEPT BioRobotics revenue

Revenue is the money a company takes in from selling its products and services, before any costs are deducted.

PROCEPT BioRobotics's revenue for the twelve months ending Jun 30, 2026 was $337.34M, up 22.7% year over year. For fiscal 2025 it was $308.05M, up 37.2% from the year before. The highest annual figure on record is $308.05M in fiscal 2025.

Annual revenue

PeriodPeriod endValueChange
FY2025Dec 31, 2025$308.05M+37.2%
FY2024Dec 31, 2024$224.50M+64.8%
FY2023Dec 31, 2023$136.19M+81.6%
FY2022Dec 31, 2022$75.01M+117.6%
FY2021Dec 31, 2021$34.47M+346.7%
FY2020Dec 31, 2020$7.72M–

Quarterly revenue

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026$94.50M+19.3%
Q1 FY2026Mar 31, 2026$83.13M+20.2%
Q4 FY2025Dec 31, 2025$76.38M+11.9%
Q3 FY2025Sep 30, 2025$83.33M+42.8%
Q2 FY2025Jun 30, 2025$79.18M+48.4%
Q1 FY2025Mar 31, 2025$69.16M+55.3%
Q4 FY2024Dec 31, 2024$68.24M+56.6%
Q3 FY2024Sep 30, 2024$58.37M+66.3%
Q2 FY2024Jun 30, 2024$53.35M+61.2%
Q1 FY2024Mar 31, 2024$44.54M+82.5%
Q4 FY2023Dec 31, 2023$43.58M+83.3%
Q3 FY2023Sep 30, 2023$35.10M+72.5%
Q2 FY2023Jun 30, 2023$33.10M+98.3%
Q1 FY2023Mar 31, 2023$24.40M+71.9%
Q4 FY2022Dec 31, 2022$23.78M+134.5%
Q3 FY2022Sep 30, 2022$20.35M+134.8%
Q2 FY2022Jun 30, 2022$16.69M+96.9%
Q1 FY2022Mar 31, 2022$14.20M+97.4%
Q4 FY2021Dec 31, 2021$10.14M+214.7%
Q3 FY2021Sep 30, 2021$8.67M+311.4%
Q2 FY2021Jun 30, 2021$8.48M–
Q1 FY2021Mar 31, 2021$7.19M–
Q4 FY2020Dec 31, 2020$3.22M–
Q3 FY2020Sep 30, 2020$2.11M–

More PROCEPT BioRobotics figures

See a number that looks wrong?